Allele-Selective Inhibition of Expression of Huntingtin and Ataxin-3 by RNA Duplexes Containing Unlocked Nucleic Acid Substitutions

被引:18
作者
Aiba, Yuichiro [1 ,2 ]
Hu, Jiaxin [1 ,2 ]
Liu, Jing [1 ,2 ]
Xiang, Qin [3 ]
Martinez, Carlos [3 ]
Corey, David R. [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
[3] Sigma Custom Prod, The Woodlands, TX 77379 USA
基金
日本学术振兴会;
关键词
MACHADO-JOSEPH-DISEASE; EXPANDED CAG REPEATS; MUTANT HUNTINGTIN; MODIFIED OLIGONUCLEOTIDES; SINGLE-NUCLEOTIDE; GENES; ANALOGS; SIRNA; STABILITY; MECHANISM;
D O I
10.1021/bi4014209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Unlocked nucleic acid (UNA) is an acyclic analogue of RNA that can be introduced into RNA or DNA oligonucleotides. The increased flexibility conferred by the acyclic structure fundamentally affects the strength of base pairing, creating opportunities for improved applications and new insights into molecular recognition. Here we test how UNA substitutions affect allele-selective inhibition of expression of trinucleotide repeat genes Huntingtin (HTT) and Ataxin-3 (ATX-3). We find that the either the combination of mismatched bases and UNA substitutions or UNA substitutions alone can improve potency and selectivity. Inhibition is potent, and selectivities of >40-fold for inhibiting mutant versus wild-type expression can be achieved. Surprisingly, even though UNA preserves the potential for complete base pairing, the introduction of UNA substitutions at central positions within fully complementary duplexes leads to >19-fold selectivity. Like mismatched bases, the introduction of central UNA bases disrupts the potential for cleavage of substrate by argonaute 2 (AGO2) during gene silencing. UNA-substituted duplexes are as effective as other strategies for allele-selective silencing of trinucleotide repeat disease genes. Modulation of AGO2 activity by the introduction of UNA substitutions demonstrates that backbone flexibility is as important as base pairing for catalysis of fully complementary duplex substrates. UNA can be used to tailor RNA silencing for optimal properties and allele-selective action.
引用
收藏
页码:9329 / 9338
页数:10
相关论文
共 46 条
[1]   Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? [J].
Alves, Sandro ;
Nascimento-Ferreira, Isabel ;
Dufour, Noelle ;
Hassig, Raymonde ;
Auregan, Gwennaelle ;
Nobrega, Clevio ;
Brouillet, Emmanuel ;
Hantraye, Philippe ;
Pedroso de Lima, Maria C. ;
Deglon, Nicole ;
de Almeida, Luis Pereira .
HUMAN MOLECULAR GENETICS, 2010, 19 (12) :2380-2394
[2]   Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice [J].
Boudreau, Ryan L. ;
McBride, Jodi L. ;
Martins, Ines ;
Shen, Shihao ;
Xing, Yi ;
Carter, Barrie J. ;
Davidson, Beverly L. .
MOLECULAR THERAPY, 2009, 17 (06) :1053-1063
[3]   Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design [J].
Braasch, DA ;
Liu, YH ;
Corey, DR .
NUCLEIC ACIDS RESEARCH, 2002, 30 (23) :5160-5167
[4]   A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects [J].
Bramsen, Jesper B. ;
Pakula, Malgorzata M. ;
Hansen, Thomas B. ;
Bus, Claus ;
Langkjaer, Niels ;
Odadzic, Dalibor ;
Smicius, Romualdas ;
Wengel, Suzy L. ;
Chattopadhyaya, Jyoti ;
Engels, Joachim W. ;
Herdewijn, Piet ;
Wengel, Jesper ;
Kjems, Jorgen .
NUCLEIC ACIDS RESEARCH, 2010, 38 (17) :5761-5773
[5]   Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals [J].
Campbell, Meghan A. ;
Wengel, Jesper .
CHEMICAL SOCIETY REVIEWS, 2011, 40 (12) :5680-5689
[6]   Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene/Allele-Specific Silencing of Mutant Huntingtin [J].
Carroll, Jeffrey B. ;
Warby, Simon C. ;
Southwell, Amber L. ;
Doty, Crystal N. ;
Greenlee, Sarah ;
Skotte, Niels ;
Hung, Gene ;
Bennett, C. Frank ;
Freier, Susan M. ;
Hayden, Michael R. .
MOLECULAR THERAPY, 2011, 19 (12) :2178-2185
[7]   Toward understanding Machado-Joseph disease [J].
Costa, Maria do Carmo ;
Paulson, Henry L. .
PROGRESS IN NEUROBIOLOGY, 2012, 97 (02) :239-257
[8]   Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing [J].
Deleavey, Glen F. ;
Damha, Masad J. .
CHEMISTRY & BIOLOGY, 2012, 19 (08) :937-954
[9]   Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits [J].
DiFiglia, M. ;
Sena-Esteves, M. ;
Chase, K. ;
Sapp, E. ;
Pfister, E. ;
Sass, M. ;
Yoder, J. ;
Reeves, P. ;
Pandey, R. K. ;
Rajeev, K. G. ;
Manoharan, M. ;
Sah, D. W. Y. ;
Zamore, P. D. ;
Aronin, N. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) :17204-17209
[10]   Sustained Effects of Nonallele-Specific Huntingtin Silencing [J].
Drouet, Valerie ;
Perrin, Valerie ;
Hassig, Raymonde ;
Dufour, Noelle ;
Auregan, Gwennaelle ;
Alves, Sandro ;
Bonvento, Gilles ;
Brouillet, Emmanuel ;
Luthi-Carter, Ruth ;
Hantraye, Philippe ;
Deglon, Nicole .
ANNALS OF NEUROLOGY, 2009, 65 (03) :276-285